Company ProfilePremium

Tofflon

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Tofflon - Healthcare showcase

Year Founded & Workforce

1993

Industry

Healthcare

Services

Core Equipment
T

Tofflon Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Tofflon Overview

Company Headquarters: Shanghai, China

Founded: 1993

Founded: 2,547

Company Working: Tofflon is involved in the manufacturing of freeze dryers, barrier systems, aseptic filling lines, plastic packaging machines, auto solution preparation systems, and many other products. The company operates through divisions, namely, Tofflon injectable, Tofflon API, Tofflon bio, and Tofflon packaging. The company constitutes five modern pharmaceutical equipment manufacturing bases with global competitiveness. These have been approved with all the international regulatory certifications, such as German TUV ISO9001, ISO14001, OHSAS 18001, CE, UL, PED, and ASME, among others. The company has operations in several countries, including the US, India, Russia, China, and several European countries. Tofflon has served more than 8000 equipment and systems to 2000 pharmaceutical companies across over 40 countries and regions in the world.

Strategy

Tofflon aims to develop and market innovative products and continuously improving existing products. The company follows a long-term growth strategy for the benefit of its clients without being focused on short-term profit. Also, the company strategizes to diversify its product portfolio by increasing the awareness of its products in the marketplace. The company aims to expand its geographical territories and become a leading global player in the freeze-drying equipment industry.

Company Snapshot

$192.2M

Revenue

1993

Founded

Shanghai, China

Headquarters

SWOT Analysis

Strengths

  • Strong know-how in the pharma freeze dryer field
  • Works closely with prominent distributors and suppliers
  • Constitutes technology collaborations with technical partners in the US, Japan, and several European countries, such as Kyowac and Praxair

Weaknesses

  • Financial instability
  • Decreasing research and development expenses

Opportunities

  • Involving into acquisitions and mergers to increase the market share
  • Global expansion

Threats

  • Stringent regulatory policies
  • High competition from existing market giants

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Product Offering

  • Tofflon
    • Core Equipment

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 192.2 Mn in 2016 to USD 289.5 Mn in 2018.
Tofflon — By Business Segment
Series (USD Mn)201620172018
Sales192.2245.4289.5
R&D Expenses13.416.114

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.